The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has appointed Bhavin Mukund Mehta, Wholetime Director of Kilitch Drugs (India) Ltd., as the Vice-Chairman of the council.

The decision underscores his significant contributions to India's pharmaceutical sector, particularly in global trade and exports.

Mehta, an industry veteran with over 25 years of experience, has been instrumental in expanding Kilitch Drugs’ presence in international markets while strengthening its foothold in India. His leadership in business development, strategic management, and global marketing is expected to be a valuable asset to Pharmexcil’s mission of promoting Indian pharmaceutical exports.

Reflecting on his appointment, Mehta expressed his enthusiasm for the new role.

"I am truly honored to be appointed as Vice-Chairman at Pharmexcil. While promoting the growth of pharmaceutical exports, I am also committed to supporting MSMEs in the industry, which play a crucial role in advancing global healthcare. Together, we will work to unlock new opportunities, drive innovation, and strengthen India’s position as a leader in pharmaceutical exports worldwide," he said.

Mehta has previously played a crucial role in the sector’s international outreach. In 2012, he was appointed Chairman of the Exhibition Committee for Pharmexcil by the Ministry of Commerce, where he contributed to the establishment of IPHEX, India’s largest pharmaceutical exhibition designed to boost exports.

A graduate of the University of Mumbai with a degree in Pharmaceutical Sciences, Mr. Mehta also holds a Post Graduate Diploma in Management from S.P. Jain Institute of Management.

Pharmexcil, established in 2004 under the Ministry of Commerce and Industry, Government of India, has been a key driver in promoting Indian pharmaceutical exports. The council provides market insights, regulatory support, and facilitates international trade fairs and exhibitions to help Indian pharmaceutical companies grow globally. Since its inception, Pharmexcil has played a vital role in making India a leading exporter of generic medicines.

Kilitch Drugs (India) Ltd., founded in 1978, is a recognized pharmaceutical manufacturer with operations in Mumbai, Ethiopia, and a new facility under development in Pen, Maharashtra. The company specializes in injectables, ophthalmic products, oral solid dosages, and nutraceuticals, meeting stringent regulatory standards, including USFDA approvals. It has successfully established a presence in several African markets and holds certifications from global regulatory bodies such as WHO-GMP, ISO 9001, and ISO 13485.

The appointment of Mehta is expected to further strengthen India’s pharmaceutical export landscape, driving innovation and expanding market reach on a global scale.